Latest CenExel News & Updates

See the latest news and media coverage for CenExel. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
CenExel

Clinical research site network

cenexelresearch.com
Headquarters
Salt Lake City, United States
Founded year
2018
Company type
Private company
Number of employees
1,000–5,000

Last updated

Latest news about CenExel

In short: CenExel appointed a new CFO, was acquired by BayPine, and contributed to the clinical trials leading to the FDA approval of Journavx.

Company announcements

CenExel

CenExel contributed to a new NEJM pain study

The Phase 2b trial evaluated LTG-001, an NaV1.8 inhibitor, and found significant pain reduction versus placebo; the high-dose group also required less opioid rescue.

CenExel

CenExel shares phase 3 trial results on xanomeline-trospium for schizophrenia

The EMERGENT-3 trial met its primary endpoint with an 8.4-point PANSS reduction versus placebo, supporting a new muscarinic antipsychotic class.

Unlock all announcements with a

Media coverage

Business Wire

BayPine to Acquire CenExel

BayPine LP (“BayPine”), a private investment firm that drives digital transformation in market-leading businesses, today announced that it has entered into a...

MENAFN

Stuart Goldblatt Joins Cenexel As Ceo

(MENAFN- GlobeNewsWire - Nasdaq) Salt Lake City, UT, July 17, 2023 (GLOBE NEWSWIRE) -- The cenexel Board of Directors is delighted to announce that Stuart...

MENAFN

Cenexel Acquires Iresearch

Salt Lake City, Utah, May 03, 2022 (GLOBE NEWSWIRE) -- CenExel announces the acquisition of iResearch ("CenExel iResearch"), a leading multi-specialty research site business with...

Unlock all articles with a

Never miss news about CenExel

Track CenExel and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.